Thursday, 25 February 2021

Sigma-Aldrich stockholders approve acquisition by Merck KGaA

11 December 2014 | News | By BioSpectrum Bureau

Sigma-Aldrich stockholders approve acquisition by Merck KGaA

(Photo Courtesy: www.tryitlocal.com)

(Photo Courtesy: www.tryitlocal.com)

Sigma-Aldrich Corp's stockholders voted to adopt the previously announced merger agreement providing for the acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, at a special meeting of stockholders.

Sigma-Aldrich stockholders also approved, on an advisory, non-binding basis, compensation that may become payable to named executive officers as a result of the acquisition.

As previously announced, on September 22, 2014, the board of directors for Sigma-Aldrich approved the merger agreement under which Merck KGaA will acquire Sigma-Aldrich for $140.00 per share in cash.

The transaction, which is expected to close in mid-2015, remains subject to the satisfaction of the closing conditions set forth in the merger agreement, including regulatory approvals.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account






Survey Box

Should we be cautious of viewing COVID-19 vaccine as silver bullet?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls